Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

4062.42 (Glytoucan)

Id:1a1af0b3-08ee-5eda-87eb-f6377b10a699

Glytoucan:G29827HT

Results found

Linked to

	Label	Description
	4062.42 has canonical residue n-glycan a-d-manp 4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G22889SE-GLYCOSEQ00025161 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G71453PT-GLYCOSEQ00184803 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G41711ZZ-GLYCOSEQ00082166 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4062.42 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000018 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4062.42 has canonical residue n-glycan b-d-galp 37 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G71309TZ-GLYCOSEQ00133435 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G77068PP-GLYCOSEQ00058165 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G06818RT-GLYCOSEQ00102038 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G39168YH-GLYCOSEQ00166219 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4062.42 has canonical residue n-glycan a-d-manp 4

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G22889SE-GLYCOSEQ00025161 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G71453PT-GLYCOSEQ00184803 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G41711ZZ-GLYCOSEQ00082166 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4062.42 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000018 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4062.42 has canonical residue n-glycan b-d-galp 37

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G71309TZ-GLYCOSEQ00133435 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G77068PP-GLYCOSEQ00058165 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G06818RT-GLYCOSEQ00102038 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4062.42 has glycosequence GLYGEN.GLYCOSEQUENCE:G39168YH-GLYCOSEQ00166219 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.